Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 161

1.

Efficacy of liposomal curcumin in a human pancreatic tumor xenograft model: inhibition of tumor growth and angiogenesis.

Ranjan AP, Mukerjee A, Helson L, Gupta R, Vishwanatha JK.

Anticancer Res. 2013 Sep;33(9):3603-9.

PMID:
24023285
2.
3.
5.

Liposome-encapsulated curcumin suppresses growth of head and neck squamous cell carcinoma in vitro and in xenografts through the inhibition of nuclear factor kappaB by an AKT-independent pathway.

Wang D, Veena MS, Stevenson K, Tang C, Ho B, Suh JD, Duarte VM, Faull KF, Mehta K, Srivatsan ES, Wang MB.

Clin Cancer Res. 2008 Oct 1;14(19):6228-36. doi: 10.1158/1078-0432.CCR-07-5177.

6.
7.

Molecular evidences for the chemosensitizing efficacy of liposomal curcumin in paclitaxel chemotherapy in mouse models of cervical cancer.

Sreekanth CN, Bava SV, Sreekumar E, Anto RJ.

Oncogene. 2011 Jul 14;30(28):3139-52. doi: 10.1038/onc.2011.23.

PMID:
21317920
8.

Curcumin-ER Prolonged Subcutaneous Delivery for the Treatment of Non-Small Cell Lung Cancer.

Ranjan AP, Mukerjee A, Gdowski A, Helson L, Bouchard A, Majeed M, Vishwanatha JK.

J Biomed Nanotechnol. 2016 Apr;12(4):679-88.

PMID:
27301194
9.

The Adnectin CT-322 is a novel VEGF receptor 2 inhibitor that decreases tumor burden in an orthotopic mouse model of pancreatic cancer.

Dineen SP, Sullivan LA, Beck AW, Miller AF, Carbon JG, Mamluk R, Wong H, Brekken RA.

BMC Cancer. 2008 Nov 27;8:352. doi: 10.1186/1471-2407-8-352.

10.

Antiangiogenic effects of a novel synthetic curcumin analogue in pancreatic cancer.

Nagaraju GP, Zhu S, Ko JE, Ashritha N, Kandimalla R, Snyder JP, Shoji M, El-Rayes BF.

Cancer Lett. 2015 Feb 28;357(2):557-65. doi: 10.1016/j.canlet.2014.12.007.

PMID:
25497868
11.

Curcumin sensitizes human colorectal cancer xenografts in nude mice to gamma-radiation by targeting nuclear factor-kappaB-regulated gene products.

Kunnumakkara AB, Diagaradjane P, Guha S, Deorukhkar A, Shentu S, Aggarwal BB, Krishnan S.

Clin Cancer Res. 2008 Apr 1;14(7):2128-36. doi: 10.1158/1078-0432.CCR-07-4722.

12.

CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.

Ruggeri B, Singh J, Gingrich D, Angeles T, Albom M, Yang S, Chang H, Robinson C, Hunter K, Dobrzanski P, Jones-Bolin S, Pritchard S, Aimone L, Klein-Szanto A, Herbert JM, Bono F, Schaeffer P, Casellas P, Bourie B, Pili R, Isaacs J, Ator M, Hudkins R, Vaught J, Mallamo J, Dionne C.

Cancer Res. 2003 Sep 15;63(18):5978-91. Erratum in: Cancer Res. 2003 Nov 1;63(21):7543.

13.

C086, a novel analog of curcumin, induces growth inhibition and down-regulation of NFκB in colon cancer cells and xenograft tumors.

Chen C, Liu Y, Chen Y, Xu J.

Cancer Biol Ther. 2011 Nov 1;12(9):797-807. doi: 10.4161/cbt.12.9.17671.

PMID:
21900746
14.
15.

Antitumor activity of emodin against pancreatic cancer depends on its dual role: promotion of apoptosis and suppression of angiogenesis.

Lin SZ, Wei WT, Chen H, Chen KJ, Tong HF, Wang ZH, Ni ZL, Liu HB, Guo HC, Liu DL.

PLoS One. 2012;7(8):e42146. doi: 10.1371/journal.pone.0042146.

16.

[Liposomal curcumin inhibits tumor growth and angiogenesis in Lewis lung cancer].

Wang LQ, Shi HS, Wang YS.

Sichuan Da Xue Xue Bao Yi Xue Ban. 2013 Jan;44(1):46-8, 75. Chinese.

PMID:
23600207
17.

Systemic delivery of liposomal short-chain ceramide limits solid tumor growth in murine models of breast adenocarcinoma.

Stover TC, Sharma A, Robertson GP, Kester M.

Clin Cancer Res. 2005 May 1;11(9):3465-74.

18.

Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice.

Aggarwal BB, Shishodia S, Takada Y, Banerjee S, Newman RA, Bueso-Ramos CE, Price JE.

Clin Cancer Res. 2005 Oct 15;11(20):7490-8.

19.

Liposome-encapsulated curcumin suppresses neuroblastoma growth through nuclear factor-kappa B inhibition.

Orr WS, Denbo JW, Saab KR, Myers AL, Ng CY, Zhou J, Morton CL, Pfeffer LM, Davidoff AM.

Surgery. 2012 May;151(5):736-44. doi: 10.1016/j.surg.2011.12.014. Retraction in: Surgery. 2016 Feb;159(2):674.

20.

Curcumin inhibits tumor growth and angiogenesis in an orthotopic mouse model of human pancreatic cancer.

Bimonte S, Barbieri A, Palma G, Luciano A, Rea D, Arra C.

Biomed Res Int. 2013;2013:810423. doi: 10.1155/2013/810423.

Items per page

Supplemental Content

Support Center